• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏磁共振在 PLN-R14del 家族中观察到的表型特征。

The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family.

机构信息

Department of Cardiology, West China Hospital, Sichuan University, Guoxue Xiang No. 37, Chengdu, Sichuan, 610041, People's Republic of China.

Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, Sichuan, China.

出版信息

Sci Rep. 2020 Oct 5;10(1):16478. doi: 10.1038/s41598-020-73359-8.

DOI:10.1038/s41598-020-73359-8
PMID:33020536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7536202/
Abstract

Phospholamban (PLN) is an important regulator for sarcoendoplasmic reticulum (SR) calcium transport ATPase (SERCA), which uptakes Ca to SR during the diastolic phase of cardiomyocytes to maintain intracellular calcium homeostasis. Mutations on PLN result in intracellular calcium disorder, myocardial contraction defect, and eventually heart failure and/or malignant ventricular arrhythmia. Since 2003, several kinds of PLN mutations have been identified in familial dilated cardiomyopathy (DCM) patients, illustrating a few clinical characteristics that differs from classical DCM patients. Herein, we report a large PLN-R14del family with typical clinical characteristics reported including relatively late-onset clinical symptoms, low-voltage in ECG, as well as frequent ventricular arrythmias. Moreover, members underwent cardiac magnetic resonance (CMR) examination showed a strikingly similar pattern of late gadolinium enhancement (LGE)-Sub-epicardial involvement in the left ventricular (LV) lateral wall with or without linear mid-wall enhancement in the interventricular septum. The former one can also present in younger PLN-R14del carriers despite completely normal LV structure and function. Meanwhile, T1 mapping also found significantly increased extracellular volume (ECV) in PLN-R14del carriers. These findings highlight the special role of CMR to phenotyping PLN-induced cardiomyopathy patients and distinguish them from other types of cardiomyopathy.

摘要

磷酸化肌球蛋白结合蛋白(PLN)是肌浆网(SR)钙转运 ATP 酶(SERCA)的重要调节因子,它在心肌细胞的舒张期将 Ca 摄取到 SR 中,以维持细胞内钙稳态。PLN 的突变导致细胞内钙紊乱、心肌收缩缺陷,最终导致心力衰竭和/或恶性室性心律失常。自 2003 年以来,已在家族性扩张型心肌病(DCM)患者中鉴定出几种 PLN 突变,这些突变与经典 DCM 患者有一些不同的临床特征。在此,我们报告了一个大型的 PLN-R14del 家族,具有典型的临床特征,包括发病症状较晚、心电图低电压以及频繁发生室性心律失常。此外,接受心脏磁共振(CMR)检查的成员显示出一种惊人相似的左心室(LV)外侧壁晚期钆增强(LGE)-心外膜下受累模式,LV 间隔的线性中层壁增强或不增强。尽管 LV 结构和功能完全正常,前者也可能发生在年轻的 PLN-R14del 携带者中。同时,T1 映射也发现 PLN-R14del 携带者的细胞外容积(ECV)显著增加。这些发现突出了 CMR 在表型 PLN 诱导的心肌病患者中的特殊作用,并将其与其他类型的心肌病区分开来。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/31486f276996/41598_2020_73359_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/284e35e03279/41598_2020_73359_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/25361513ebdc/41598_2020_73359_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/31486f276996/41598_2020_73359_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/284e35e03279/41598_2020_73359_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/25361513ebdc/41598_2020_73359_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83aa/7536202/31486f276996/41598_2020_73359_Fig3_HTML.jpg

相似文献

1
The phenotypic characteristic observed by cardiac magnetic resonance in a PLN-R14del family.心脏磁共振在 PLN-R14del 家族中观察到的表型特征。
Sci Rep. 2020 Oct 5;10(1):16478. doi: 10.1038/s41598-020-73359-8.
2
Genetic deletion of arginine 14 in phospholamban causes dilated cardiomyopathy with attenuated electrocardiographic R amplitudes.受磷蛋白中精氨酸14基因缺失影响,会导致扩张型心肌病,同时心电图R波振幅减弱。
Heart Rhythm. 2009 Apr;6(4):480-6. doi: 10.1016/j.hrthm.2009.01.016. Epub 2009 Jan 18.
3
The human phospholamban Arg14-deletion mutant localizes to plasma membrane and interacts with the Na/K-ATPase.人磷酸化酶抑素 Arg14 缺失突变体定位于质膜,并与 Na/K-ATP 酶相互作用。
J Mol Cell Cardiol. 2012 Mar;52(3):773-82. doi: 10.1016/j.yjmcc.2011.11.012. Epub 2011 Dec 1.
4
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy.磷酸化肌球蛋白结合蛋白 R14del 突变在诊断为扩张型心肌病或致心律失常性右室心肌病患者中的意义:支持致心律失常性心肌病概念的证据。
Eur J Heart Fail. 2012 Nov;14(11):1199-207. doi: 10.1093/eurjhf/hfs119. Epub 2012 Jul 20.
5
A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia.一种新的人类R25C-受磷蛋白突变与钙循环的超抑制和室性心律失常有关。
Cardiovasc Res. 2015 Jul 1;107(1):164-74. doi: 10.1093/cvr/cvv127. Epub 2015 Apr 7.
6
Isoform changes of action potential regulators in the ventricles of arrhythmogenic phospholamban-R14del humanized mouse hearts.心律失常性磷蛋白兰巴因 R14del 人源化小鼠心室中动作电位调节剂同工型变化。
Metabolism. 2023 Jan;138:155344. doi: 10.1016/j.metabol.2022.155344. Epub 2022 Nov 12.
7
Unfolded Protein Response as a Compensatory Mechanism and Potential Therapeutic Target in PLN R14del Cardiomyopathy.未折叠蛋白反应作为 PLN R14del 心肌病的代偿机制和潜在治疗靶点。
Circulation. 2021 Aug 3;144(5):382-392. doi: 10.1161/CIRCULATIONAHA.120.049844. Epub 2021 Apr 30.
8
Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca Handling and Arrhythmogenesis.异常的 PLN-R14del 蛋白相互作用加剧 SERCA2a 抑制,导致钙处理和心律失常发生受损。
Int J Mol Sci. 2022 Jun 22;23(13):6947. doi: 10.3390/ijms23136947.
9
Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)-Related Cardiomyopathy: Development of PLN-R14del-Related Cardiomyopathy.蛋白聚集是磷酸化酶烯醇化酶 p.(Arg14del)相关心肌病的早期表现:PLN-R14del 相关心肌病的发生。
Circ Heart Fail. 2021 Nov;14(11):e008532. doi: 10.1161/CIRCHEARTFAILURE.121.008532. Epub 2021 Sep 30.
10
Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy.与人类 R14del-Phospholamban 心肌病相关的肌丝改变。
Int J Mol Sci. 2023 Jan 31;24(3):2675. doi: 10.3390/ijms24032675.

引用本文的文献

1
Genetic landscape of phospholamban cardiomyopathies.受磷蛋白心肌病的遗传图谱
Front Cell Dev Biol. 2025 Jun 10;13:1626242. doi: 10.3389/fcell.2025.1626242. eCollection 2025.
2
Calcium handling remodeling in dilated cardiomyopathy: From molecular mechanisms to targeted therapies.扩张型心肌病中的钙处理重塑:从分子机制到靶向治疗
Channels (Austin). 2025 Dec;19(1):2519545. doi: 10.1080/19336950.2025.2519545. Epub 2025 Jun 16.
3
Identification and validation of hypoxia-responsive signature pathways in human cardiomyocytes.

本文引用的文献

1
[Association between phospholamban gene mutation and dilated cardiomyopathy in the Chengdu area].[成都地区磷蛋白基因变异与扩张型心肌病的相关性]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2005 Sep;36(5):683-5.
2
[Association between mutation of phospholamban gene and dilated cardiomyopathy].[磷酸受磷蛋白基因突变与扩张型心肌病的关联]
Yi Chuan. 2004 Sep;26(5):599-602.
人类心肌细胞中缺氧反应性特征通路的鉴定与验证
3 Biotech. 2025 Apr;15(4):103. doi: 10.1007/s13205-025-04271-z. Epub 2025 Mar 31.
4
Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies.肥厚型心肌病:临床研究对病理生理学及新型治疗策略的见解
Egypt Heart J. 2025 Jan 7;77(1):5. doi: 10.1186/s43044-024-00600-4.
5
Cardiac Applications of CRISPR/AAV-Mediated Precise Genome Editing.CRISPR/腺相关病毒介导的精准基因组编辑在心脏领域的应用
bioRxiv. 2024 Dec 4:2024.12.03.626493. doi: 10.1101/2024.12.03.626493.
6
The phospholamban R14del generates pathogenic aggregates by impairing autophagosome-lysosome fusion.肌浆网磷蛋白 R14del 通过损害自噬体-溶酶体融合产生致病聚集体。
Cell Mol Life Sci. 2024 Nov 11;81(1):450. doi: 10.1007/s00018-024-05471-1.
7
Reassessing the Mechanisms of PLN-R14del Cardiomyopathy: From Calcium Dysregulation to S/ER Malformation.重新评估PLN-R14del心肌病的机制:从钙调节异常到S/ER畸形
JACC Basic Transl Sci. 2024 Apr 17;9(8):1041-1052. doi: 10.1016/j.jacbts.2024.02.017. eCollection 2024 Aug.
8
The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy.遗传学在扩张型心肌病风险分层策略中的作用
Rev Cardiovasc Med. 2022 Sep 9;23(9):305. doi: 10.31083/j.rcm2309305. eCollection 2022 Sep.
9
Phospholamban R14del disease: The past, the present and the future.受磷蛋白R14缺失影响的疾病:过去、现在与未来
Front Cardiovasc Med. 2023 Apr 18;10:1162205. doi: 10.3389/fcvm.2023.1162205. eCollection 2023.
10
Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca Handling and Arrhythmogenesis.异常的 PLN-R14del 蛋白相互作用加剧 SERCA2a 抑制,导致钙处理和心律失常发生受损。
Int J Mol Sci. 2022 Jun 22;23(13):6947. doi: 10.3390/ijms23136947.